Northern Trust
AURA icon

Northern Trust’s Aura Biosciences AURA Stock Holding History

Northern Trust’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
549,462
+118,940
+28% +$851K ﹤0.01% 2757
2026
Q1 		$2.88M Buy
430,522
+17,713
+4% +$102K ﹤0.01% 2772
2025
Q4 		$2.25M Sell
412,809
-20,832
-5% -$124K ﹤0.01% 2930
2025
Q3 		$2.68M Buy
433,641
+63,169
+17% +$413K ﹤0.01% 2869
2025
Q2 		$2.32M Sell
370,472
-4,046
-1% -$23.7K ﹤0.01% 2902
2025
Q1 		$2.19M Sell
374,518
-12,751
-3% -$96.5K ﹤0.01% 2876
2024
Q4 		$3.18M Buy
387,269
+23,006
+6% +$217K ﹤0.01% 2774
2024
Q3 		$3.25M Buy
364,263
+71,931
+25% +$617K ﹤0.01% 2716
2024
Q2 		$2.21M Sell
292,332
-3,991
-1% -$29.2K ﹤0.01% 2849
2024
Q1 		$2.33M Buy
296,323
+47,892
+19% +$397K ﹤0.01% 2882
2023
Q4 		$2.2M Buy
248,431
+26,842
+12% +$227K ﹤0.01% 2947
2023
Q3 		$1.99M Buy
221,589
+8,351
+4% +$89.8K ﹤0.01% 2942
2023
Q2 		$2.63M Buy
213,238
+17,817
+9% +$190K ﹤0.01% 2850
2023
Q1 		$1.81M Buy
195,421
+51,606
+36% +$536K ﹤0.01% 2983
2022
Q4 		$1.51M Sell
143,815
-1,286
-0.9% -$16.4K ﹤0.01% 3124
2022
Q3 		$2.63M Buy
145,101
+12,409
+9% +$188K ﹤0.01% 2867
2022
Q2 		$1.88M Buy
132,692
+86,621
+188% +$1.43M ﹤0.01% 3097
2022
Q1 		$1.01M Buy
46,071
+196
+0.4% +$3.73K ﹤0.01% 3409
2021
Q4 		$779K Buy
+45,875
New +$820K ﹤0.01% 3635

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Northern Trust's AURA Position: Q2 2026 in Review

Northern Trust increased its Aura Biosciences (AURA) stake by 28% in Q2 2026, buying an estimated $851K and bringing the position to 549,462 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Northern Trust first reported a position in AURA in Q4 2021 and has held it in 19 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Northern Trust held 549,462 shares of Aura Biosciences worth $3.9M as of Q2 2026.
  • Northern Trust bought 118,940 Aura Biosciences shares in Q2 2026, an estimated $851K.
  • Aura Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2757 holding.
  • Northern Trust first reported a position in Aura Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.